 Cost implications different approaches prevention respiratory distress syndrome incidence neonatal respiratory distress syndrome neonatal mortality corticosteroids women preterm surfactant babies high risk hyaline membrane disease effects adoption preventive policies costs neonatal care effects treatment overviews relevant controlled trials costs observations care neonatal unit results policies babies weeks gestation drug cost pounds less/baby overall costs care cost survivor drug cost high pounds policies babies weeks gestation policies reduction cost /survivor survival policies increase overall costs babies weeks gestation